Meningococcal A, C, Y and W-135 Conjugate Vaccine
Classification:
Products in the Pipeline
- Product Description
- Immunogenicity
- Security
- Mad Dog Bite Cases
-
Manufacturing Process
The project employs customized animal-free medium to reduce the risk of contamination by animal-derived pathogenic factors. It also employs novel purification technology to further ensure the safety. The lyophilized vaccine exhibits a superior stability.
Current Progress
Preparations are underway for Phase I clinical trial.
Previous Page
Previous Page
Other Products
Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)
SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)
Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV 13)
Recombinant Human Papillomavirus 15-valent Vaccine (Escherichia. Coli) (HPV 15)
Follow us
Telephone
Marketing Center
International Trade
Medical Consultation
Address
No.1, XinFang Street, Hunnan New District, Shenyang City
123456789
12456789